Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia

AIM: This post hoc analysis of a double‐blind (DB), randomized, placebo‐controlled, relapse‐prevention study evaluated the effects of paliperidone palmitate once‐every‐3‐months (PP3M) in a subpopulation of adults with early illness schizophrenia (duration ≤5 years) from a clinical trial. METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell Lynum, Karimah S., Turkoz, Ibrahim, Kim, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585630/
https://www.ncbi.nlm.nih.gov/pubmed/29968279
http://dx.doi.org/10.1111/eip.12685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585630/
https://www.ncbi.nlm.nih.gov/pubmed/29968279
http://dx.doi.org/10.1111/eip.12685

Ejemplares similares